In recent weeks, two Calls for proposals were published that offer relevant funding opportunities for hematologists: IMI2 – 18^th Call for proposals, a jointly funded partnership between the European Union, and Horizon 2020 – Call for cancer research proposals, call for research proposals in the category ‘Societal Challenge 1 (SC1): Health, demographic change and wellbeing’. . 

In 2014 the European Parliament approved the Clinical Trials Regulation (CTR) that is supposed to replace the Clinical Trials Directive (CTD) from 2001. Five years later, the regulation has not yet become applicable. What is the aim of the ‘new’ regulation, what issues does it address, and why was its application delayed?

2019 will see significant changes within the European institutions. The first already took place in late May, as 50% of EU citizens – the highest turnout since 1994 – went to the ballot box to elect their Members of the European Parliament (MEPs). The result: Confirmation that nationalism and Euroscepticism are on the rise, and a set-back of center political parties.

EHA President, John Gribben and member of the SEHH, María Victoria Mateos On Thursday, June 20 the Spanish Society of Hematology (SEHH) officially celebrated its 60th anniversary with a commemorative event…

More than 12,000 hematology professionals from around the world met together in Amsterdam, The Netherlands for the 24th European Hematology Association (EHA) Congress.

He started at EHA in the early days when it was still being run by a small office in Rotterdam. Now, EHA has grown and he's still with us. Meet Ton Hagenbeek and learn about what he's doing for EHA and why he has been volunteering through out all these years! 

Onco-hematology was the focus of the two-day EHA Hematology Tutorial in Moscow, Russia, the third joint tutorial organized by EHA, the National Hematological Society (NHS) and the Russian-Oncohematology Society (ROHS). The first edition was held in 2013 in St Petersburg, the second in Moscow in 2016 and now in Moscow again.

Patient-centric treatments such as gene and cell therapies have been a game-changer in tackling hematological disorders. Nonetheless, their development remains slow and erratic, limiting benefit for patients.

Learning how to recognize and treat a disease that is relatively new to many parts of Europe, and spreading, is crucial to limit, if not avoid, irreversible impact and provide proper care to patients.

The 8^th EHA-TSH Hematology Tutorial was held on April 6-7, 2019 in Izmir, Turkey. This marks yet another pleasant and fruitful collaboration between EHA and the Turkish Society of Hematology. This time, the tutorial focused on the topic of lymphoma and was chaired by Prof Anton Hagenbeek (NL) on behalf of EHA, and Prof Guner Hayri Özsan (TU) on behalf of TSH.

Maria Victoria Mateos currently heads the Scientific Program Committee of the 24^th EHA Congress which will be held on June 13-16 in Amsterdam. She started volunteering for EHA in 2013 and is still an EHA Volunteer under the mentorship of Prof Jordi Sierra and current EHA President Prof Pieter Sonneveld. Why did she become a volunteer and what keeps her going? Read more.

After a successful first edition in 2017, EHA and the Sri Lanka College of Haematologists (SLCH) organized its second two-day tutorial together in February in Colombo.

The European Hematology Association (EHA) has endorsed and signed a collective Call to Action, prepared by the European Society for Medical Oncology (ESMO), on shortages of inexpensive, essential medicines. Such shortages have a direct impact on patient care across Europe and require collaborative action at EU level.

EHA, in collaboration with the Kazakhstan Cancer Society (KCS) and Kazakh Institute of Oncology and Radiology (KazIOR), organized its very first tutorial together on March 14-16 in Almaty, Kazakhstan.

April 9, Brussels - The European Alliance for Personalised Medicine is holding its 7th annual presidency conference at the University Foundation in Brussels, and the event will include a session…